✦ LIBER ✦

Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): Histamine H3 receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity

✍ Scribed by Hudkins, Robert L.; Josef, Kurt A.; Becknell, Nadine C.; Aimone, Lisa D.; Lyons, Jacquelyn A.; Mathiasen, Joanne R.; Gruner, John A.; Raddatz, Rita

Book ID: 122187419
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 582 KB
Volume: 24
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2014.01.061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery and Characterization of 6-{4-[

Discovery and Characterization of 6-{4-[3-( R )-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2 H -pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H 3 Receptor Inverse Agonist

✍ Hudkins, Robert L.; Raddatz, Rita; Tao, Ming; Mathiasen, Joanne R.; Aimone, Lisa 📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 1007 KB

Pharmacological characterisation and inh

Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A2A receptor agonist and adenosine A3 receptor antagonist activity

✍ Nicola Bevan; Peter R. Butchers; Rick Cousins; Jill Coates; Emma V. Edgar; Val M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Pharmacological Characterization of MK-0

Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

✍ Salvatore, C. A.; Hershey, J. C.; Corcoran, H. A.; Fay, J. F.; Johnston, V. K.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 370 KB